Business
AstraZeneca moves to start making a profit from its vaccine – Sydney Morning Herald
After looking on as Pfizer and Moderna have made billions of dollars in sales, AstraZeneca is shifting to a for-profit model.
The vaccine isnt yet authorised in the US, after the company missed the window for an emergency authorisation due to the complicated nature of its trial results. Astra is planning to submit the shot for approval to regulators in the first half of next year,…
Continue Reading
-
Noosa News20 hours agoTop chefs rally for Noosa Reds farmers Pete and Dory
-
General16 hours agoPM kicks off roundtable with call for lasting reform
-
General15 hours agoTrial of celebrity crocodile wrangler Matt Wright to hear from more witnesses
-
Business15 hours agoUp 44% since April, why this dividend paying ASX 300 energy stock could keep running hot